The effects of the aqueous extract of Pterocarpus santalinus heartwood and vitamin E supplementation in streptozotocin-induced diabetic rats

Journal of Medicinal Plant Research

Volumn 5, Issue 3, 2011, Pages 398-409

  Halim, M Eshrat ^a   Misra, Anoop ^b  

^a HAMDARD UNIVERSITY   (India)

^b FORTIS HOSPITAL   (India)

Author keywords

Antioxidant; Catalase; Diabetic nephropathy; Lipid peroxidation; Malondialdehyde; Pterocarpus santalinus l; Red sandal wood; Streptozotocin induction; Thiobarbituric acid reactive substance (TBARS); Vitamin E

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; CATALASE; CHOLESTEROL; CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID PEROXIDASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PLANT EXTRACT; RED SANDALWOOD EXTRACT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BRAIN TISSUE; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIVER; MALE; MONOTHERAPY; MUSCLE TISSUE; NONHUMAN; PTEROCARPUS; RAT; RED SANDALWOOD; RENAL PROTECTION; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

PTEROCARPUS SANTALINUS; RATTUS; RATTUS NORVEGICUS;

EID: 84856182870     PISSN: None     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Aebi HU (1983). Catalase in Methods in enzymatic analysis (ed.) H U Bergmeyer New York: Academic Press), 3: 276-286.
2. Agewall S, Wilkstran J, Ljungman S, Fagerbaerg B (1997). Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Am. J. Cardiol., 80: 164-169.
3. Basavanagowdappa H, Prabhakar AK, Prasannaraj P, Gurudev KC, Virupaksha S (2005). Study of prevalence of Diabetes Mellitus and impaired fasting glucose in a rural population. Int. J. Diabetes Dev. Countr., 25: 98-101.
4. Baynes JW, Thorpe SR (1999). Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes, 48: 1-9.
5. Beers RF, Sizer, LW (1952). A Spectrophotometric Method for measuring the breakdown of hydrogen peroxide by Catalase. J. Biol. Chem., 195: 133-140.
6. Bhor VM, Raghuram N, Sivakami S (2004). Oxidative damage and altered Antioxidant Enzyme activities in the small intestine of streptozotocin- induced diabetic rats. The Int J. Biochem., Cell Biol., 36: 89-97.
7. Ceriello A (2000).Oxidative stress and glycemic regulation. Metabolism. 49: 27-29.
8. Chatterjea MN, Shinde R (2002).Text Book of Medical biochemistry. Fifth ed.Jaypee Brothers, Medical Publishers (P) Ltd., New Delhi, 17.
9. Cojocel CA, Maghrebi M, Thomon MS, Rawoot R, Pathy R (2005). Modulation of the transforming growth factor β1by Vitamin E in Early Nephropathy. Int. J. Kuwait Univ. Health Sci. Centre, 14: 422-429.
10. Cory SH, Lambert JSA, Coonishish J, Louis CM, Cuerrier A, Pierre S, Haddad J, Arnason T, Steffany ALB (2008). Anti diabetic Activity of Extracts from needle, Bark, and Cone of Picea glauca: Organ - Specific Protection from Glucose Toxicity and Glucose Deprivation Pharmaceutical Biology, 46: 126-134.
11. De Angelis KL, Cestaxi IA, Barp J, Dall A, Fernandes TG, Homem de Bitlen Court PI, Bello A, Klein A, Bello AA, Liesuy S, Irigoyen MC (2000). Oxidative stress in the latissimus dorsi muscle of diabetic rats. Brazilian J. Med. Biol. Res., 33: 1363-1368.
12. Doumas B, Biggs H (1972). G. Standard Methods of Clinical Chemistry. Academic Cooper, editor Press, New York, 7: 175-188.
13. Eddouks M, Maghrani M, Lemhadri A, Ouahidi ML, Jouad H (2002). Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J. Ethnopharmacol., 82: 97-103.
14. Eshrat HM (2003). Lowering of blood sugar by water extract of Azadirachta indica and Abroma augusta in diabetes rats. Indian J. Experimental Biol., 41: 636-640.
15. Eshrat HM (2003). Effect of Coccinia indica (L.) and Abroma augusta (L.) on glycemia, lipid Profile and on indicators of end organ damage in streptozotocin-induced diabetic rats. Indian J. Clin. Biochem., 18: 54-63.
16. Friedewald WT, Levy RI, Fred RDS (1972). Estimation of the concentration of low- Density lipoprotein in cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem., 18: 499-502.
17. Gupta D, Raju J, Prakash J, Baquer NZ (1999). Change in the Lipid profile: lipogenic and related enzymes in the livers of experimental diabetic rats; effect of a insulin and vanadate. Diabetes Res. Clin. Pract., 46:1-7.
18. Harris CS, Louis-Philippe B, Marie-Helene F, Kristina L, Mclntyre PL, Owen, Louis C, Martineau, Alain Currier, Timothy Johns, Pierre S, Haddad, SAL, Bennett J, Arnason T (2010). Inhibition of Advanced Glycation End Product Formation by Medicinal Plant Extracts Correlates with Phenolic Metabolites and Antioxidant Activity, Planta Med. Aug. 17 E-publication.
19. Harbilas D, Martineau LC, Harris CS, Adeyiwola-Spoor DC, Saleem A, Lambert J, Caves D, Johns T, Prentki M, Cuerrier A, Arnason JT, Bennett SA, Haddad PS (2009). Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadain boreal forest used to treatsymptoms of diabetes: part II. Can J. Physiol. Pharmacol., 87: 479-492.
20. Hunt JV, Smith CC, Wolff SP (1990). Antioxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes, 39: 14200-1424.
21. Kalender B, Ozturk M, Tunedemir M, Uysal O, Dagistanli FK, Yegenaga I, Evek EI (2002). Renoprotective effects of valartan and enalapril in streptozotocin-induced diabetic rats. Acta Histochemica., 104: 123-130.
22. Kumar N, Sanduja SK, Kukla AS, Seshadri TR (1976). Sesquiterpenoids of Pterocarpus santalinus heart wood: Absolute configuration of pterocarpol. Indian J. Chem., 14: 405-407.
23. Kasneswara RB, Giri R, Kesavulu MM, Apparao C (2001). Effect of oral administration of bark extracts of Pterocarpus santalinus L on blood glucose level in experimental animals. J. Ethnopharmacol., 74: 69-74.
24. Konditi VK, RaJasekhar KR, Sampath MKMT, Sammeea SF Ramesh BK, Chippada AR (2010). Effect of Pterocarpus santalinus bark, on blood glucose, serum lipids, plasma insulin and hepatic carbohydrate metabolic enzymes in streptozotocin - induced diabetic rats. Food and Chemical Toxicol., 48: 1281-1287.
25. Krishnamurthy A, (Ed.). Pterocarpus santalinus In. The wealth of India, Raw Materials, Vol. 8, Council of Scientific and Industrial Research, New Delhi, Fist Ed (1969).
26. Kröncke KD, Fehsel K, Summer A, Rodriguez ML, Kolb-Bachofen V (1995). Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-nitroso-urea: Streptozotocin contributes to islet cell DNA damage. Biol. Chem., Hoppe-Seyler, 376: 179-185.
27. Kumar N, Sandoval SK, Ravindranath B, Seshadri TR (1976). Terpenoids of Pterocarpus Santalinus heart wood Phytochem., 13: 633-636.
28. Kwon HJ, Kwon HJ, Hong YK, Kim KH, Han CH, Choj JS, Byung KW (2006). Methanolic extract of Pterocarpus santalinus shown to exhibit ant inflammations and anticancer effects and methanolic extract shown cytotoxic activity J. Ethnopharmacol., 105: 229-234.
29. Lawrence RA, Burk RF (1976). Glutathione peroxidase activity in selenium- deficient rat liver. Biochem. Biophysical Res. Commun., 71: 952-958.
30. Lehmann R, Schleicher ED (2000). Molecular mechanism of diabetic nephropathy. Clinica Chemical Acta., 297: 135-144.
31. Letitia M, McCune TJ (2002). Antioxidant activity in medicinal plants associated with the symptoms of Diabetes Mellitus used by the Indigenous Peoples of the North Am. Boreal For. J. Ethnopharmacol., 82: 197-205.
32. Louis C, Martineau D, Alain Cuerrier E, Pierre S, Haddad D, John T, Arnason T, Steffany ALB (2008). Antidiabetic Activity of Extracts from Needle, Bark, And Cone of Picea glauca: Organ-Specific Protection from Glucose Toxicity and Glucose Deprivation Pharmaceut., Biol., 46: 126-134.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin Phenol reagent. J. Biol. Chem., 193: 265-275.
34. Maheshwari JK, Singh KK, Saha S (1980). Ethnomedicinal uses of plants by Tharus in Kheri Distt UP. Bul Medico. Enthnobot. Res., 1: 318-337.
35. Marles RJ, Farnsworth, NR (1995). Antidiabetic plants and their active constituents. Phytomed., 2: 137-189.
36. Miranda-Gardurio LM, Reza AA (2008). Obesity, inflammation and diabetes Gaceta Medica de Mexico, 144: 39-46.
37. Misra A, Singhal N, Khurana L (2010). Obesity, the metabolic syndrome, and type 2 diabetes 1n developing countries role of dietary fats and oils. J. Am. Coll. Nutr., 29: 289S-301S.
38. Misra HP, Fridovich I (1972). The role of superoxide anion in the auto - oxidation Of Epinephrine and a simple assay for superoxide dismutae. J. Biolog. Chem., 247: 3170-3185.
39. Nagaraju, N, Prasad M, Gopalakrishna G (1991). Blood sugar lowering effect of Petrocarpus santalinus (red sandal) wood extract in different rat models. Int. J. Pharmacog., 29: 141-144.
40. Nawroth PP, Isermann B (2010). Mechanisms of Diabetic Nephropathy - old buddies and newcomers part1. Exp. Clin. Endocrinal Diabetes, 118: 571-576.
41. Nicholas SB, Mauer M, Basgin JM, Agiusniga E, Chon Y (2004). Effect of Angiotensin II on glomerular structure in streptozotocin induced diabetic rats. Am. J. Nephrol., 24: 549-546.
42. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006). Prevalence of overweight and obesity in the United States, J. Am. Med. Assoc., 295: 1549-1555.
43. Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95: 351-358.
44. Osawat KY (2005). Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann. New York Acad. Sci., 1043: 440-451.
45. Parving HH, Tarnow L, Crossing P (1997). Renal protection in Diabetes - an emerging role for calcium antagonists. Cardiol., 88: 56-62.
46. Patrick J, Manning M, Robert J, Sylvia A, Shelia MM, Anne R, Elizabeth A (2004). Effect of high-dose vitamin E on insulin resistance and associated parameters in overweigh subjects. Diabetes Care, 27: 2166-2171
47. Plamen HY, Zhivka AB (2009). Primary prevention of nephropathy in Obese type 2 diabetic patient Cent. Eur. J. Med., 4(3): 379-381.
48. Poliodoro GDI, Ilio C, Arduini A, La Roveve G, Federici G (1984). Superoxide dissimulates reduced glutathione and TBA - reactive products in erythrocytes of patients with multiplesclerosis. Int. J. Biochem., 16: 505-509.
49. Pradhan A (2007). Obesity, Metabolic syndrome, and type 2 Diabetes Inflammatory Basis of Glucose Metabolic Disorders. Nutr. Rev., 65: S152-S156.
50. Schleicher E, Friess U (2007). Oxidative stress, AGE, and atherosclerosclerosis. Kidney Int., 106: S17-S26.
51. Surya VS, Ingeborg MB, Bruijn AJ (2010). Pathologic Classification of Diabetic Nephropathy. J. Am. Soc. Nephrol., 21: 556-563.
52. Tervaert TW, Mooyarrt AL, Amannk, Cohen AH, Drachenberg CB, Franco F, Agnes BF, Mark H, Emile DH, Kensuke J, Laure H, Noe J, Radha K, Surya V, Seshan I, Bajema M, Bruijn JA (2010). Pathologic Classification of Diabetic Nephropathy. J. Am. Soc. Nephrol., 21: 556-563.
53. Thijs W, Cohen T, Antien L M, Kerstin A, Arthur H, Cohen H, Terence C, Cinthia BD, Franco F, Agnes BF, Mark H, Emile de H, Kensuke J, Laure H, Noe JRK (2010). Pathologic Classification of Diabetic Nephropathy. J. Am. Soc. Nephrol., 2: 1270-1274.
54. Vasavada N, Agarwal R (2005). Role of oxidative stress in diabetic nephropathy. Adv. Chronic Kidney Dis., 12: 146-154.
55. Vedel P, Obel J, Nielsen FS, Bang LE, Svendsen TL, Pedersen OB, Parving HH (1996). Glomerularhyper filtration in microalbuminuric NIDDM patients. Diabetologia, 39: 1584-1589.
56. Warrier PK, Nambiar VK, Ramankutty C (1995). Indian Medicinal plants. Orient Longman Limited, Madras, pp. 381-383.
57. Wendell A (1981). Glutathione peroxidase, in Methods in Enzymology, Ed, Jakoby, W.B, Academic Press, New York (USA), 77: 327-333.
58. Willey DG, Rosenthal MA, Caldwell S (1984). Glycosylated haemoglobin and plasma glycoprotein assay by affinity chromatography. Diabetologia, 27: 56-58.
59. Yotsumoto T, Naitoh T, Shikada, K, Sakuya I, Tanaka, T (1997). Effects of Specific Antagonists of Angiotensin Receptors and Captoprilon Diabetic Nephropathy in Mice. Japanese. J. Pharmacol., 75: 59-64.
60. Youdim KA, Joseph JA (2001). A Possible emerging role of photochemical in improving age-related neurological dysfunctions-a multiplicity of effects, Free Radical Biology Medicine. 30: 583-594.
61. Yu Y, Lyons T J (2005). A lethal tetrad in diabetes hyperglycemic oxidative stress, and endothelial dysfunction. Am. J. Med. Sci., 330: 227-232.
62. Zargar A H, Wani A I, Masaodi S R, Laway B A, Bashir MI (1999). Mortality Diabetes Mellitus data from a developing region of the world. Diabetes Res. Clin. Pract., 43: 67-74.